Selected article for: "antigenic drift and neutralizing activity"

Author: Graham, Carl; Seow, Jeffrey; Huettner, Isabella; Khan, Hataf; Kouphou, Neophytos; Acors, Sam; Winstone, Helena; Pickering, Suzanne; Galao, Rui Pedro; Dupont, Liane; Lista, Maria Jose; Jimenez-Guardeño, Jose M.; Laing, Adam G.; Wu, Yin; Joseph, Magdalene; Muir, Luke; van Gils, Marit J.; Ng, Weng M.; Duyvesteyn, Helen M.E.; Zhao, Yuguang; Bowden, Thomas A.; Shankar-Hari, Manu; Rosa, Annachiara; Cherepanov, Peter; McCoy, Laura E.; Hayday, Adrian C.; Neil, Stuart J.D.; Malim, Michael H.; Doores, Katie J.
Title: Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
  • Cord-id: kp3yodxc
  • Document date: 2021_4_1
  • ID: kp3yodxc
    Snippet: Interaction of the SARS-CoV-2 Spike receptor binding domain (RBD) with the receptor ACE2 on host cells is essential for viral entry. RBD is the dominant target for neutralizing antibodies, and several neutralizing epitopes on RBD have been molecularly characterized. Analysis of circulating SARS-CoV-2 variants has revealed mutations arising in the RBD, N-terminal domain (NTD) and S2 subunits of Spike. To understand how these mutations affect Spike antigenicity, we isolated and characterized >100
    Document: Interaction of the SARS-CoV-2 Spike receptor binding domain (RBD) with the receptor ACE2 on host cells is essential for viral entry. RBD is the dominant target for neutralizing antibodies, and several neutralizing epitopes on RBD have been molecularly characterized. Analysis of circulating SARS-CoV-2 variants has revealed mutations arising in the RBD, N-terminal domain (NTD) and S2 subunits of Spike. To understand how these mutations affect Spike antigenicity, we isolated and characterized >100 monoclonal antibodies targeting epitopes on RBD, NTD, and S2 from SARS-CoV-2-infected individuals. Approximately 45% showed neutralizing activity, of which ∼20% were NTD specific. NTD-specific antibodies formed two distinct groups: the first was highly potent against infectious virus, whereas the second was less potent and displayed glycan-dependant neutralization activity. Mutations present in B.1.1.7 Spike frequently conferred neutralization resistance to NTD-specific antibodies. This work demonstrates that neutralizing antibodies targeting subdominant epitopes should be considered when investigating antigenic drift in emerging variants.

    Search related documents:
    Co phrase search for related documents
    • acute sars cov respiratory syndrome coronavirus and low decrease: 1, 2, 3
    • acute sars cov respiratory syndrome coronavirus and low infectivity: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute sars cov respiratory syndrome coronavirus and low neutralization: 1, 2, 3, 4, 5
    • acute sars cov respiratory syndrome coronavirus and low neutralization potency: 1
    • acute sars cov respiratory syndrome coronavirus and low percentage: 1, 2, 3, 4, 5, 6
    • acute sars cov respiratory syndrome coronavirus and mab epitope: 1, 2, 3, 4
    • acute sars cov respiratory syndrome coronavirus and mabs detect: 1, 2
    • acute sars cov respiratory syndrome coronavirus and mabs neutralization: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute sars cov respiratory syndrome coronavirus and mabs report: 1, 2, 3, 4, 5, 6, 7
    • acute sars cov respiratory syndrome coronavirus and mabs specific: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute sars cov respiratory syndrome coronavirus and mabs spike bind: 1
    • acute viral infection and low percentage: 1